Three forces to join forces to create a global influence of the Yangtze River Delta Biopharmaceutical Industrial Park

Pharmaceutical Network Industry Dynamics: Biopharmaceutical industry is one of the high-tech industries with potential for development, now whether it is large traditional pharmaceutical enterprises, or small and medium-sized biotechnology companies are gradually realizing that solid innovation, in the face of global market competition, has become the only way to survive and develop, but no longer one of the options
Focusing on the field of biomedicine, on April 9, Greenfield HoldingS Group signed a strategic cooperation agreement with Shanghai University of Traditional Chinese Medicine and Shanghai Pharmaceutical Group Co., Ltd., and the three parties will focus on the field of biomedicine to carry out in-depth cooperation across the industry chain, build a Yangtze River Delta Biomedicine, Medical Materials Industrial Park with global influence, explore the integrated industrial promotion model of "Industrial Parks and Innovation Incubators, Industry Funds and Industry Alliances" to create a benchmark for biomedicine, medical materials industry
Shanghai University of Traditional Chinese Medicine is one of the four higher education institutions of Chinese medicine established in the country after the birth of New China, and is a high-level university in ShanghaiShanghai Pharma, as a pharmaceutical industry group listed in Shanghai and Hong Kong as a whole, is a leader in the research and development, production and distribution markets of pharmaceutical productsGreenfield Holdings will give full play to its multi-industry advantages and capital, global resources and other advantages, integration of all parties in the industrial base, technological advantages, human resources and other favorable conditionsThis tripartite cooperation will shape the model of innovation and development of biomedicine and medical materials industry, further promote the Yangtze River Delta region to develop into a biopharmaceutical innovation source with international influence and biomedicine, medical materials industry cluster area, and will choose the opportunity to expand to the whole country
Medical materials are the country's basic strategic materials, China has listed biomedicine as a key development of strategic emerging industries, biopharmaceutical industry has entered a period of rapid development, in the future development of the global industry has an important positionIt is reported that in December 2019 issued the Yangtze River Delta Regional Integration Development Plan outline, clearly the Yangtze River Delta region as a new round of high-quality development of one of the top ten focusing industrial areas, will build a number of strategic emerging industries baseThis year issued the "strengthening the construction of Chinese medicine" related documents, but also clearly vigorously promote the development of the Chinese medicine industry
The Greenfield Holding Group and Shanghai University of Traditional Chinese Medicine, Shanghai Pharmaceutical Group Co., Ltdthree strong cooperation, all parties will innovate cooperation model, around the Shanghai University of Traditional Chinese Medicine and its affiliated medical institutions research and development results, relying on Shanghai Pharma in drug research and development, clinical research, industrial production and sales network and other aspects of the green space in infrastructure, science and technology, health, capital and industrial park construction, and other comprehensive advantages, joint scientific and technological research and talent training, scientific research and implementation of research and development cooperationCreate a resource-integrated innovation platform
It is understood that the co-built biopharmaceutical industry park will be characterized by Chinese medicine, scientific research into the core, to promote the "production, research and medical" integrated development
Among them, the industrial sector to the Chinese medicine industry as the main body, Chinese medicine business as the hub, to promote the chinese medicine formula particles, Chinese medicine tablets of the large-scale development, the layout of high-end medical equipment and high-value medical supplies, to achieve the localization of high-end medical equipment, Chinese medicine diagnostic equipment intelligent, and promote the Yangtze River Delta medical supplies emergency reserve supply chain construction
The teaching sector closely combines the needs of the industry and the clinical needs, integrates Chinese medicine with modern medical theory and humanistic spirit, and builds a high-level composite medical personnel training system
The research plate uses big data, information technology and other means to innovate and develop Chinese and Western medicine combined diagnosis and treatment methods and equipment, explore new Chinese medicine, set up standardized research institutes, and raise industry standards
Application plate to research-oriented Chinese hospital as the core, strengthen clinical research capacity, clinical diagnosis and treatment capacity, results conversion capacity, to create a national model of scientific research results transformation
The park will also build a complete public service platform, import market-oriented industry funds, regularly hold high-end international academic forums, to create a new demonstration of Chinese medicine characteristics of the world biomedicine
The three strong and powerful forces will give priority to the establishment of a global leading biomedicine and medical materials industrial park in the Yangtze River Delta integrated region, create a biopharmaceutical industry to cluster the development of the ecological environment, build a differentiated core competitiveness of regional high-quality development, accelerate the formation of new dynamic steam, and promote the high-quality development of the Yangtze River Delta economy.